SCHEDULE.
| 10:00 am – 02:00 pm | Title: CA21135 – Immuno-model: Modelling immunotherapy response and toxicity in cancer | ||
| 5:00 pm – 7:00 pm | Keynote Lecture - Aaron Ciechanover, Nobel Prize in Chemistry 2004 |
| 08:30 am – 09:00 am | Sorina Badelita, MD | Fundeni Clinical Institute, Bucharest, Romania | |
| 09:00 am – 09:30 am | Gabriel Ghiaur, MD | The Johns Hopkins University School of Medicine, Baltimore, USA AML non-promotional educational session organized with the support of AbbVie |
|
| 09:30 am – 10:00 am | Jessica Altman, MD | Feinman School of Medicine Northwestern University, Chicago, USA AML non-promotional educational session organized with the support of AbbVie |
|
| 10:00 am – 10:30 am : | B. Douglad Smith, MD | The Johns Hopkins University School of Medicine, Baltimore, USA |
|
| 10:30 am – 10:50 am : | Janssen Romania Symposium | ||
| 10:50 am – 11:10 am : | Janssen Romania Symposium | ||
| 11:10 am – 12:00 pm : | Novartis Symposium Florian Heidel M.D. PV-AIM study presentation |
||
| 12:00 pm – 12:30 pm : | BMS symposiums Ciprian Tomuleasa, M.D. |
Department of Hematology - Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania |
INREBIC in terapia mielofibrozei |
| 12:30 am – 1:00 pm : | Lunch Break | ||
| 1:00 pm – 1:30 pm : | Melody Smith, M.D. | Stanford University, Stanford, USA | |
| 1:30 pm – 2:00 pm : | Eunice Wang, MD | Roswell Park Comprehensive Cancer Center, USA | |
| 2:00 pm – 2:20 pm : | Janssen Romania Symposium | ||
| 2:20 pm – 2:40 pm : | Janssen Romania Symposium | ||
| 2:30 pm – 3:00 pm : | Laura Belver, Ph.D. | Josep Carreras Leukemia Research Institute, Barcelona, Spain |
|
| 3:00 pm – 3:45 pm: | Roche Symposiums Anca Bojan, M.D. |
Department of Hematology - Oncological Institute "Prof. Dr. Ion Chiricută" Cluj-Napoca |
Looking Beyond Bleeds: What Else Is Important For Patients with HA? Clinical outcomes with HEMLIBRA in the IOCN |
| Roche Symposiums Moderator: Mihnea Zdrenghea M.D. Speaker: Ciprian Tomuleasa M.D. |
Department of Hematology - Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania |
DLBCL. The opportunity of first-line treatment | |
| 3:00 pm – 3:30 pm: | Accord symposiums Horia Bumbea, M.D., Ph.D |
Spitalul Universitar de Urgenta Bucuresti | Impactul primei linii de tratament asupra rezultatului procedurii de transplant in Mielom Multiplu |
| 3:30 pm – 3:50 pm: | Takeda Symposium Ciprian Tomuleasa, M.D. |
Department of Hematology - Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania |
|
| 3:50 pm – 4:10 pm: | Takeda Symposiums Delia Dima, M.D. |
Department of Hematology - Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania |
|
| 4:10 pm – 4:40 pm: | AstraZeneca symposiums | ||
| 4:40 pm – 5:00 pm : | Takeda Symposiums Ciprian Tomuleasa, M.D. |
Department of Hematology - Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania |
|
| 5:00 pm – 5:30 pm : | AstraZeneca symposiums Speaker: Ciprian Tomuleasa M.D. |
||
| 5:30 pm – 5:50 pm : | BMS symposiums Mihnea Zdrenghea M.D. |
Department of Hematology - Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania |
Maintenance in AML: Oral Azacitidine |
| 5:50 pm – 6:50 pm : | Genesis Pharma symposium | ||
| 6:50 pm – 7:20 pm : | Hillard Lazarus, MD | Editor in Chief – Blood Reviews |
| 8:30 pm - 09:00 am: | Eric Oksenhendler, MD, | Hôpital Saint-Louis, Paris, France | |
| 9:00 pm - 09:30 am: | Evangelos Terpos, MD | School of Medicine, National and Kapodistrian University of Athens |
|
| 09:30 am – 10:30 am: | Astellas symposium | ||
| 10:30 am – 11:00 am: | Jaroslav Cermak, M.D. | Institute of Hematology and Blood Transfusion, Prague, Czech Republic |
|
| 11:00 am – 11:30 am: | Sebastian Kobold, MD University of München, Germany |
DLBCL non-promotional educational session organized with the support of AbbVie |
|
| 11:30 am – 12:00 am: | Pfizer symposium | ||
| 12:00 pm – 12:30 pm: | Pfizer symposium | ||
| 12:30 pm – 1:00 pm: | Polina Stepensky, MD | The Hebrew University of Jerusalem, Jerusalem, Israel | |
| 1:00 pm – 1:15 pm: | Sobi Symposium Adina Trăilă, MD |
„Cristian Șerban” Medical Assessment and Rehabilitation Center for Children and Youth, Buziaș, Romania |
Efmoroctocog alfa – Extended half-life FVIII in clinical practice- one answer to multiple patients’ profiles |
| 1:15 pm – 1:30 pm: | Sobi Symposium Ciprian Tomuleasa, MD |
"Ion Chiricuta" The Oncology Institute Cluj-Napoca, Romania |
Unlocking New Potential: Oral Therapy’s Swift and Sustained Effect |
| 1:30 pm – 2:00 pm: | LUNCH BREAK | ||
| 2:00 pm – 2:30 pm: | Hermann Einsele, MD. | Julius Maximilians University Würzburg, Germany | |
| 2:30 pm – 2:45 pm: | Sanofi symposium | ||
| 3:00 pm – 3:20 pm: | Pfizer symposium | ||
| 3:20 pm – 3:40 pm: | Pfizer symposium | ||
| 3:40 pm – 4:00 pm: | Pfizer symposium | ||
| 4:00 pm – 4:30 pm: | Erik Oksenhendler, M.D. | Clinical Immunology at Hopital Saint-Louis in Paris |
Networking in very rare diseases. French experience in Castleman disease |
| 4:30 pm - 5:00 pm: | AOP Orphan symposium Ciprian Tomuleasa, M.D. |
Department of Hematology - Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania |
|
| 5:00 pm - 5:30 pm: | Jonatham Fromm, M.D. | University of Washington, Seattle, USA | |
| 5:30 -6:00 pm: | Company symposiums | ||
| 06:00 pm: | Closing remarks |